(R)-1-Cyclohexanecarbonylpyrrolidin-3-amine hydrochloride, 1g

2-Amino-4-naphthalen-2-yl-thiophene-3-carboxylic acid methyl ester, 95+%, 1g

1-Bromo-5-phenylpentane, 97.0%, 1g

1-(4,6-Dimethylpyrimidin-2-yl)piperidine-4-carboxylic acid, 95.0%, 1g

3-Hydroxybutyric acid (sodium), 1kg

5-Methoxy-2-methyl-4-nitroaniline, 95.0%, 1g

2-Bromo-5-(trifluoromethyl)benzodifluoride (stabilized over Potassium carbonate), 1g

(9aS)-octahydro-1H-pyrido[1,2-a]piperazine; oxalic acid, 95.0%, 250mg

Acide tungstophosphorique hydraté, pa, cristallisé, 500 g, emballage verre

2,3,5-Tribromo-6-methylpyridine, 95.0%, 1g

2-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole, 97%, 1g

Methyl 6-bromo-4-chloropicolinate, 97.0%, 100mg

2-Methyl-2-(methyl(oxetan-3-yl)amino)propanal, 97%, 5g